METROPOLISMetropolis Health.

₹2030.8+1.31%

Market Cap

₹10,529.97 Cr

Stock P/E

66.55

ROCE

17.59%

ROE

12.07%

Book Value

₹264.04

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

•
Strong organic growth plus acquisitions has driven revenue expansion.
•
Q1 EBITDA margin remained robust at 24.7%, indicating improved efficiency.

NEGATIVES

•
Q1 PAT is negative due to high depreciation and interest in Core; refinancing expected to improve Q2.
•
Near-term margin drag from newly acquired labs and Co-diagnostics before full integration gains.

Peers Summary

Sector Leader

Metropolis Healthcare Ltd. shows moderate growth and profitability metrics relative to its peers in the Hospital & Healthcare Services sector. While it has a high PE ratio indicating potential overvaluation, its solid ROE and low debt levels make it a stable choice. Companies like Apollo Hospitals and Max Healthcare exhibit stronger profitability and growth, making them sector leaders, while Aster DM Healthcare is notably undervalued despite its financial struggles.

Key Points

• Metropolis Healthcare shows moderate growth and profitability metrics.
• Apollo Hospitals and Max Healthcare lead in profitability and growth.
• Aster DM Healthcare is undervalued yet financially weak.

Top Performers

Apollo Hospitals Enterprise Ltd.

Highest ROE (20.51%) and solid EPS growth (100.56) despite higher valuation.

Max Healthcare Institute Ltd.

Strong revenue growth (18.49% YoY) and high ROE (13.47%).

Explore

Watchlists

Command Palette